Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a ...

Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a ...

IRVINE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that near real-time real-world data on the iLet Bionic Pancreas is now publicly available…

Beta Bionics makes iLet Bionic Pancreas data publicly available

A user wears the iLet automated insulin delivery system. [Image courtesy of Beta Bionics]Beta Bionics (Nasdaq:BBNX) today announced the public availability of near-real-time, real-world iLet Bionic Pancreas data. Irvine, California-based Beta Bionics said its dashboard publishes outcomes for 100% of iLet patients who meet two simple, pre-stated criteria (a provider-reported baseline HbA1c and at least two weeks of data uploaded to the cloud), wi…